ReviewCNS spectrums2025

Should glutamatergic modulators be considered preferential treatments for adults with major depressive disorder and a reported history of trauma? Conceptual and clinical implications.

Kayla M Teopiz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.